Supervisor Database Search
Guidance for ICAT Supervisors
The ICAT Supervisor list is reviewed annually by the partner universities and updated online in March/April each year.
You can read about the ICAT supervisor selection process and eligibility criteria below:
Terms of reference/guide to supervising ICAT Fellows.
You can read the terms of reference for supervisors actively supervising ICAT Fellows below:
Supervisor Database
Search for supervisors below. You can filter your search using the options and select multiple fields by holding CTRL (Cmd on Mac) + clicking multiple options in a list.
Full NameProfessor Laurence Egan
- infectious disease and the immune system
- cell and developmental biology/regenerative medicine
- physiology and non-communicable disease
- cancer/oncology
- bioengineering/medical devices
- Medicine
- Gastroenterology
- Pharmacology
The research group of Professor Egan is focussed on optimising treatment approaches for individual patients with inflammatory bowel diseases. We also have an interest in understanding better some of the complications of inflammatory bowel disease, most notably the development of colon cancer. Some of our key discoveries in the past include elucidation of the key role of the transcription factor NFκB in the pathophysiology of colitis and colitis associated colon cancer, radiation enteritis and colon cancer metastasis.
Other work has focused on developing a better understanding of the mechanisms of resistance to treatment with anti-TNF monoclonal antibodies such as infliximab. Our most recent results indicate that infliximab exerts profound effects on circulating blood monocytes. Current work is investigating whether the effect of infliximab on this key pro-inflammatory cell type is a particular of treatment resistance versus response in inflammatory bowel disease patients.